Institutional Ownership Actinium Pharmaceuticals, Inc. (ATNM)
This table provides information about the institutional ownership of Actinium Pharmaceuticals, Inc. (ATNM). We have compiled data on the 64 institutions that hold shares in the stock, with a total of 6.8 Million shares, which have been reported (via 13F filing form) to have a value of $8.84 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Nov 04, 2025 Q3 2025 |
542
shares
|
$704
0.0% of portfolio
|
Q4 2024
New holding
|
|
|
Jones Financial Companies Lllp
|
Nov 04, 2025 Q3 2025 |
351
shares
|
$456
0.0% of portfolio
|
Q3 2025
Added 17.0%
|
|
|
Pittenger & Anderson Inc
|
Nov 03, 2025 Q3 2025 |
341
shares
|
$443
0.0% of portfolio
|
Q1 2025
New holding
|
|
|
Groupe La Francaise
Paris, I0 |
Nov 13, 2025 Q3 2025 |
316
shares
|
$410
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Investors Research Corp
|
Jan 06, 2026 Q4 2025 |
300
shares
|
$390
0.0% of portfolio
|
Q2 2025
Added 20.0%
|
|
|
Northwestern Mutual Wealth Management CO
|
Nov 14, 2025 Q3 2025 |
107
shares
|
$139
0.0% of portfolio
|
Q3 2020
New holding
|
|
|
Ever Source Wealth Advisors, LLC
|
Nov 10, 2025 Q3 2025 |
86
shares
|
$111
0.0% of portfolio
|
Q3 2025
Reduced 60.0%
|
|
|
Srs Capital Advisors, Inc.
Denver, CO |
Nov 14, 2025 Q3 2025 |
34
shares
|
$44
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
4
shares
|
$5
0.0% of portfolio
|
Q3 2025
Reduced 99.84%
|
|
|
True Wealth Design, LLC
Akron, OH |
Oct 21, 2025 Q3 2025 |
2
shares
|
$2
0.0% of portfolio
|
Q3 2025
Reduced 91.67%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
1
shares
|
$1
0.0% of portfolio
|
Q3 2025
Reduced 99.95%
|
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|